Literature DB >> 24099868

Shingles in Alberta: before and after publicly funded varicella vaccination.

Margaret L Russell1, Douglas C Dover2, Kimberley A Simmonds3, Lawrence W Svenson4.   

Abstract

PURPOSE: A universal publicly funded chickenpox vaccination program was implemented in Alberta in 2002. We examine the epidemiology of medically attended shingles in Alberta from 1994 to 2010.
METHODS: Incident shingles cases (earliest health service utilizations for ICD-9 053 or ICD-10-CA B02) and their co-morbid conditions for the 12 months prior to shingles diagnosis were identified from the records of Alberta's universal, publicly funded health-care insurance system for 1994-2010. Shingles diagnostic codes at least 180 days after the first were classified as recurrent episodes. Denominators for rates were estimated using mid-year population estimates from the Alberta Health Care Insurance Plan Registry. Annual age- and sex-specific rates were estimated. We estimated the proportion of all cases that were hospitalized. We explored the pattern of rates for sex, age-group co-morbidity and year effects and their interactions.
RESULTS: Crude rates of shingles increased over the interval 1994-2010. Most persons had only a single episode of shingles; 4% of cases were hospitalized. Shingles rates were higher among females than males. While only 2% of shingles cases had one or more co-morbidities, this proportion was also higher for females than males. Prior to 2002, all age groups of both sexes experienced increasing annual rates of shingles. However, there was a sharp decline in the rate of shingles for both females and males under the age of 10 years for 2002-2010, the period in which there was publicly funded chickenpox vaccination.
CONCLUSION: The declining rates of shingles among persons under the age of 10 years are consistent with an impact of the chickenpox vaccination program. The trend of increasing rates of shingles among older persons began prior to implementation of vaccination.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Alberta/epidemiology; Herpes zoster/epidemiology; Herpes zoster/prevention and control; Population surveillance

Mesh:

Substances:

Year:  2013        PMID: 24099868     DOI: 10.1016/j.vaccine.2013.09.018

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  21 in total

1.  Trends in Nationwide Herpes Zoster Emergency Department Utilization From 2006 to 2013.

Authors:  Erica D Dommasch; Cara J Joyce; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2017-09-01       Impact factor: 10.282

2.  Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling study.

Authors:  Mélanie Drolet; Zhou Zhou; Chantal Sauvageau; Philippe DeWals; Vladimir Gilca; Rachid Amini; Élodie Bénard; Marc Brisson
Journal:  CMAJ       Date:  2019-08-26       Impact factor: 8.262

3.  THE JEREMIAH METZGER LECTURE VARICELLA ZOSTER VIRUS: FROM OUTSIDE TO INSIDE.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

4.  Incidence of varicella and herpes zoster after inclusion of varicella vaccine in national immunization schedule in Turkey: time trend study.

Authors:  Ahmet Soysal; Erdem Gönüllü; İsmail Yıldız; Metin Karaböcüoğlu
Journal:  Hum Vaccin Immunother       Date:  2020-07-23       Impact factor: 3.452

5.  The temporal impact of aging on the burden of herpes zoster.

Authors:  Lijoy Varghese; Baudouin Standaert; Antonio Olivieri; Desmond Curran
Journal:  BMC Geriatr       Date:  2017-01-23       Impact factor: 3.921

6.  Risk of febrile seizures after first dose of measles-mumps-rubella-varicella vaccine: a population-based cohort study.

Authors:  Shannon E MacDonald; Douglas C Dover; Kimberley A Simmonds; Lawrence W Svenson
Journal:  CMAJ       Date:  2014-06-09       Impact factor: 8.262

7.  Links between herpes zoster incidence and childhood varicella vaccination.

Authors:  Craig M Hales; Rafael Harpaz; Stephanie R Bialek
Journal:  Ann Intern Med       Date:  2014-04-15       Impact factor: 25.391

8.  Summary of the NACI Update on Herpes Zoster Vaccines.

Authors:  R Warrington; S Ismail
Journal:  Can Commun Dis Rep       Date:  2018-09-06

9.  A systematic literature review of herpes zoster incidence worldwide.

Authors:  Désirée van Oorschot; Hilde Vroling; Eveline Bunge; John Diaz-Decaro; Desmond Curran; Barbara Yawn
Journal:  Hum Vaccin Immunother       Date:  2021-03-02       Impact factor: 3.452

10.  Twenty Years of Medically-Attended Pediatric Varicella and Herpes Zoster in Ontario, Canada: A Population-Based Study.

Authors:  Anne E Wormsbecker; Jun Wang; Laura C Rosella; Jeffrey C Kwong; Chi Yon Seo; Natasha S Crowcroft; Shelley L Deeks
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.